Loading...
Immunotherapy Trials for Type 1 Diabetes: The Contribution of George Eisenbarth
Type 1 diabetes (T1D) results from the autoimmune destruction of pancreatic β-cells, and as such it should respond to immunotherapy. George Eisenbarth gave many significant contributions to this field. He has been involved at some level in most immunotherapy trials during the past three decades. He...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Mary Ann Liebert, Inc.
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3676656/ https://ncbi.nlm.nih.gov/pubmed/23786294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2013.0107 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|